COMMUNITY

ÃÖ°íÀÇ ±â¼ú·Â°ú ÃÖ»óÀÇ Ç°Áú,
ÂøÇÑ °¡°ÝÀ¸·Î º¸´äÇÏ¿© µå¸®°Ú½À´Ï´Ù.

Ä¿¹Â´ÏƼ
Community

  • Ȩ
  • Ä¿¹Â´ÏƼ
  • ÇÁ·Î¸ð¼Ç

ÇÁ·Î¸ð¼Ç

ÇÑÁ¤±â°£ ¾Æ¹Ù¹ÙÀÌ¿À Á¦°øÇϴ Ưº°ÇÑ °¡°Ý
Á¦¸ñ [Cell applications] Primary Airway Cells | COVID-19
ÀÛ¼ºÀÚ abbabio
ÀÛ¼ºÀÏÀÚ 2020-04-06
Á¶È¸¼ö 309
Trouble viewing this email? Read it online
COVID-19 update: Cell Applications, Inc. is committed to continued support of researchers around the world combating the COVID-19 pandemic. Our essential personnel are working hard to fulfill research needs without interruption.
During these uncertain times, the research community works tirelessly to try to find treatments for COVID-19, the respiratory disease caused by the coronavirus SARS-CoV-2. To support of these efforts, Cell Applications, Inc. remains operational. Furthermore, we are providing a panel of Airway Cell Total Kits -- primary cells & optimized media -- for respiratory research during this global crisis.
For more information about the Airway Cell culture systems, visit the links below:
Bronchial Epithelial Cell Total Kits:
Tracheal Epithelial Cell Total Kits:
Small Airway Epithelial Cell Total Kits:
Lung Microvascular Endothelial Cell Total Kits:
Lung Fibroblast (HLF) Total Kits Cat# 506K-05


Contact us:

Toll Free: 800-645-0848

cellapplications.com

A GMP facility proudly serving the global research community for more than 26 years.
÷ºÎÆÄÀÏ